University of Texas Southwestern Medical Center
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Texas Southwestern Medical Center sits in the top decile of US sponsors by registered trial count (#39 of 15,742 sponsors by registered trial count).
University of Texas Southwestern Medical Center: 837 sponsored US clinical trials, 162 recruiting.
University of Texas Southwestern Medical Center sponsors 837 registered US clinical trials on ClinicalTrials.gov, 162 of them currently recruiting, and 503 completed. 126 of these trials are in Phase 3-4 (later-stage) and 228 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Hypertension, with 9 trials.
Top-decile sponsor footprint
University of Texas Southwestern Medical Center ranks in the top decile of sponsors by registered trial count (#39 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
503 of 608 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (82.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
837 total, page 3 of 17
Effectiveness of Repositioning and Cranial Remolding in Infants With Cranial Deformation
NCT05917678
Bladder Cancer Screening Trial
NCT05646485
Safety, Efficacy, and Pharmacokinetics of Tafamidis in Patients With Transthyretin-mediated Amyloidosis Post Orthotopic Heart Transplantation
NCT05489523
Pathways Relating Amnestic MCI to a Mild Traumatic Brain Injury History
NCT05446584
VITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid Tumors
NCT04796012
Multicomponent Intervention Study- Blood Donors With High Cholesterol
NCT05693701
Heat Waves and the Elderly - Cooling Modalities
NCT05484739
Outcomes of Focal Ablation for Prostate Cancer
NCT05478694
Patients With and Without Phonotrauma
NCT05625191
Neoadjuvant Lenvatinib and Pembrolizumab for IVC Tumor Thrombus
NCT05319015
Laryngeal Cryotherapy for Refractory Neurogenic Cough
NCT05665244
Subclinical Transthyretin Cardiac Amyloidosis in V122I TTR Carriers
NCT05489549
Propofol and Etomidate Admixtures Comparisons Trial (PEAC Trial)
NCT05358535
Impact of Dietary Phosphate Excess on Exercise Capacity and Visceral Adiposity
NCT05147909
Assessing the Efficacy of Targeted Home Visits in the Management of Chronic Conditions
NCT05168605
Cancer Clinical Trials Financial Reimbursement Program
NCT05402033
Preventing Cognitive Decline by Reducing BP Target Trial
NCT05106036
South Asians and Coronary Plaque Registry
NCT05367297
Brain Metabolism Observed at 7 Tesla
NCT05085704
CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer
NCT05029999
CLOZAPINE Response in Biotype-1
NCT04580134
Motor Network Physiology
NCT04957095
Effects of Obesity in the Aged
NCT05028309
Gemcitabine Versus Water Irrigation in Upper Tract Urothelial Carcinoma
NCT04865939
Markers of Osteoporosis in Cystic Fibrosis
NCT03921060
Sympathetic Transduction in Obesity-associated Hypertension (OB-HTN)
NCT04838678
Ultra-fractionated Radiotherapy for Rectal Cancer
NCT04677413
Non-Invasive Testing to Evaluate Wound Healing in Diabetes
NCT04232631
Single Cell Immune and Non-immune Correlates of Response to Neoadjuvant Abemaciclib
NCT04614194
POCUS: Hemostatic Potential and Joint Health in Patients With Severe Hemophilia A on Novel Replacement Therapies
NCT04690322
The Modulatory Effect of Female Sex Hormones on Spinal Neuroplasticity
NCT06656819
Hyperinflation Respiratory Therapies in Cardiac Surgery Patients
NCT04164173
Peri-Operative Immune Checkpoint Inhibition and Cryoablation in Women With Triple-negative Breast Cancer
NCT03546686
An Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or Biopsy
NCT04623502
Pharmacological Modulation of Brain Oscillations in Memory Processing
NCT05594017
Effect of Transcutaneous Electrical Nerve Stimulation on Post-stroke Patients
NCT06541015
Cerebellar tDCS in Children With Autism Spectrum Disorder
NCT04446442
Metabolic Characteristics of Brain Tumors Using Hyperpolarized Carbon-13 Magnetic Resonance Spectroscopic Imaging (MRSI)
NCT03067467
Preventing Vulnerable Child Syndrome in the NICU With Cognitive Behavioral Therapy (PreVNT Trial)
NCT03906435
Facilitating Diagnostics and Prognostics of Parkinsonian Syndromes Using Neuroimaging
NCT03872102
Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active Surveillance
NCT03769766
Multimodal Monitoring of Cerebral Autoregulation After Pediatric Brain Injury
NCT04242602
Identification of Metabolic Phenotypes Associated With Melanoma Metastasis
NCT06400550
Dystonia Genotype-Phenotype Correlation
NCT03428009
Neurocognitive Decline in Patients With Brain Metastases
NCT03508752
Resilience in Adolescent Development
NCT03458936
Dallas 2K: A Natural History Study of Depression
NCT02919280
Multiple System Atrophy Multidisciplinary Clinic
NCT03811808
Establishing Normative Data for Pupillometer Assessments in Neuro-Intensive Care
NCT02804438
JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer
NCT02468024
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 106 |
| Phase 2 | 122 |
| Phase 3 | 28 |
| Phase 4 | 98 |
Therapeutic Areas
What is open in the University of Texas Southwestern Medical Center pipeline
162 recruiting of 837 indexed (19% open); 503 completed (60%).
Phase mix: 126 late (III/IV) vs 228 early (I/II) (early-phase heavy).
Top condition: Hypertension (9 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Texas Southwestern Medical Center: open-pipeline peers nationwide
Peers matched on 837 registered trials and 19% open enrollment, not the therapeutic-area sidebar.
University of Texas Southwestern Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 837 trials (± recruiting share)
- University of Utah · 818 trials · 17% recruiting
- University of Chicago · 796 trials · 20% recruiting
- Indiana University · 890 trials · 18% recruiting
- Dana-Farber Cancer Institute · 781 trials · 14% recruiting
Sponsors near 19% open enrollment (± trial volume)
- California Polytechnic State University-San Luis Obispo · 19% recruiting · 26 trials
- Phoenix Children's Hospital · 19% recruiting · 26 trials
- Ann & Robert H Lurie Children's Hospital of Chicago · 19% recruiting · 159 trials
- Vanderbilt University Medical Center · 19% recruiting · 677 trials
Related
What to do with this University of Texas Southwestern Medical Center page
837 registered trials is a research-attention snapshot, not an endorsement of University of Texas Southwestern Medical Center or any single study.
- 162 of University of Texas Southwestern Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Hypertension is the condition University of Texas Southwestern Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Hypertension trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Texas Southwestern Medical Center pipeline card: 837 registered trials from official public datasets.Report a data error.